Effect of liver transplant on pulmonary functions in adult patients with alpha 1 antitrypsin deficiency: 7 Cases

Experimental and Clinical Transplantation

Volumn 8, Issue 1, 2010, Pages 4-8

  Jain, Ashokkumar B ^a   Patil, Vrishali ^b   Sheikh, Baber ^a   Apostolakos, Michael ^c   Ryan, Charlotte ^b   Kashyap, Randeep ^b   Orloff, Mark ^b  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

A1A; Liver transplantation; Pulmonary functions

Indexed keywords

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; ASCITES; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GRAFT SURVIVAL; HUMAN; LIVER GRAFT; LIVER TRANSPLANTATION; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; PLEURA EFFUSION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; SMOKING; SURVIVAL RATE;

ADULT; ALPHA 1-ANTITRYPSIN DEFICIENCY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; PLEURAL EFFUSION; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SMOKING;

EID: 77749309868     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Anthony S. Fauci DLK, Dan L. Longo, et al. Harrison Priciples of Internal Medicine. 17th ed. New York: McGraw-Hill Companies, Inc.; 2008.
2. RNM MacSween, BC Portmann, KG Ishak, PJ Scheuer, PP Anthony. Pathology of the Liver. 4th ed. London: Churchill Livingstone; 2002.
3. Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet. 2005;365(9478):2225-2236.
4. van Steenbergen W. Alpha 1-antitrypsin deficiency: an overview. Acta Clin Belg. 1993;48(3):171-189.
5. Lomas DA, Evans DL, Finch JT, Carrell RW. The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature. 1992;357(6379):605-607.
6. Perlmutter DH. The cellular basis for liver injury in alpha 1-antitrypsin deficiency. Hepatology. 1991;13(1):172-185.
7. Perlmutter DH. Clinical manifestations of alpha 1-antitrypsin deficiency. Gastroenterol Clin North Am. 1995;24(1):27-43.
8. Sveger T. The natural history of liver disease in alpha 1-antitrypsin deficient children. Acta Paediatr Scand. 1988;77(6):847-851.
9. Vennarecci G, Gunson BK, Ismail T, et al. Transplantation for end stage liver disease related to alpha 1 antitrypsin. Transplantation. 1996;61(10):1488-1495.
10. Piitulainen E, Sveger T. Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ). Thorax. 2002;57(8):705-708.
11. Abboud RT, Ford GT, Chapman KR. Alpha1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society. Can Respir J. 2001;8(2):81-88.
12. Abboud RT, Ford GT, Chapman KR. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome? Treat Respir Med. 2005;4(1):1-8.
13. Pierce JA. Alpha1-antitrypsin augmentation therapy. Chest. 1997;112(4):872-874.
14. Stockley RA, Bayley DL, Unsal I, Dowson LJ. The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 2002;165(11):1494-1498.
15. Stoller JK, Fallat R, Schluchter MD, et al. Augmentation therapy with alpha1-antitrypsin: patterns of use and adverse events. Chest. 2003;123(5):1425-1434.
16. Vidal Pla R, Padulles Zamora N, Sala Pinol F, Jardi Margaleff R, Rodriguez Frias F,Montoro Ronsano JB. Pharmacokinetics of alpha1-antitrypsin replacement therapy in severe congenital emphysema. Arch Bronconeumol. 2006;42(10):553-556.
17. Ward AC, Keogh BA. Intravenous alpha-1-antitrypsin replacement therapy: case report after one year of treatment. Ir J Med Sci. 1997;166(1):7-9.
18. Esquivel CO, Vicente E, Van Thiel D, et al. Orthotopic liver transplantation for alpha-1-antitrypsin deficiency: an experience in 29 children and ten adults. Transplant Proc. 1987;19(5):3798-3802.
19. Kemmer N, Kaiser T, Zacharias V, Neff GW. Alpha-1-antitrypsin deficiency: outcomes after liver transplantation. Transplant Proc. 2008;40(5):1492-1494.
20. PutnamCW, Porter KA, Peters RL, AshcavaiM, Redeker AG, Starzl TE. Liver replacement for alpha1-antitrypsin deficiency. Surgery. 1977;81(3):258-261.
21. De Roover A, Detry O, Honore P, et al. Alpha-1-antitrypsin deficiency. An indication for pediatric liver transplantation (French). Rev Med Liege. 2001;56(11):753-758.
22. Filipponi F, Soubrane O, Labrousse F, et al. Liver transplantation for end-stage liver disease associated with alpha-1-antitrypsin deficiency in children: pretransplant natural history, timing and results of transplantation. J Hepatol. 1994;20(1):72-78.
23. Prachalias AA, Kalife M, Francavilla R, et al. Liver transplantation for alpha-1-antitrypsin deficiency in children. Transpl Int. 2000;13(3):207-210.
24. The Alpha-1-Antitrypsin Deficiency Registry Study Group. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. Am J Respir Crit Care Med. 1998;158(1):49-59.
25. Seersholm N, Wencker M, Banik N, et al. Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. Eur Respir J. 1997;10(10):2260-2263.